Funder: Cholangiocarcinoma Foundation
Due Dates: September 18, 2026 (LOI portal opens) | October 9, 2026, 11:59 p.m. US Eastern (LOI) | November 20, 2026 (LOI decision) | January 4, 2027, 11:59 p.m. US Eastern (Invited full application)
Funding Amounts: Up to $75,000 for one year (June 1, 2027–May 31, 2028)
Summary: Supports early-career researchers worldwide conducting basic, translational, and clinical cholangiocarcinoma research to improve patient outcomes and advance a cure.
Key Information: Applicants must be postdoctoral or clinical fellows without faculty positions at application, with an institution-assigned research mentor.
Description
The Cholangiocarcinoma Foundation (CCF) established its Research Fellowship Program in 2015 to support early-career, innovative researchers worldwide studying cholangiocarcinoma, or bile duct cancer. The program provides seed funding to deepen understanding of this complex disease and accelerate progress toward a cure. Prior experience in cholangiocarcinoma research is not required.
The fellowship supports basic science using laboratory models without patient clinical data, translational science using human samples or sample-derived data annotated with clinical outcomes, and clinical science studying human patient outcomes, including population and epidemiology research. CCF emphasizes research that can affect patient outcomes, hypothesis-driven aims, well-designed analyses, statistical rigor, and projects feasible within the award period. Collaboration among researchers, institutions, and industry—and sharing information, samples, and expertise—is central to the program.
